Inhibrx Biosciences (INBX) Property, Plant & Equipment (Net) (2023 - 2025)

Inhibrx Biosciences (INBX) Property, Plant & Equipment (Net) (2023 - 2025) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Property, Plant & Equipment (Net) (Qtr)
1	Oculis Holding AG	67,102.16 Bn	67,101.87 Bn	-	642,333.36
2	Nanobiotix	1,908.96 Bn	1,908.90 Bn	-	5.32 Mn
3	Akari Therapeutics	959.56 Bn	959.56 Bn	-	-
4	BeOne Medicines	474.03 Bn	469.24 Bn	1.35 Bn	1.64 Bn
5	Vertex Pharmaceuticals	122.13 Bn	114.88 Bn	2.59 Bn	1.61 Bn
6	Regeneron Pharmaceuticals	70.09 Bn	61.34 Bn	3.31 Bn	5.27 Bn
7	Belite Bio	62.34 Bn	62.34 Bn	-	-
8	Argenx Se	55.96 Bn	50.77 Bn	1.41 Bn	1.96 Bn
9	Alnylam Pharmaceuticals	37.53 Bn	34.52 Bn	959.66 Mn	518.26 Mn
10	Inhibrx Biosciences	1.26 Bn	1.26 Bn	-	3.73 Mn

Download Data